Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 dose-finding and safety study of a new Shigella vaccine with adjuvant
NL-OMON58847Phase 1Completed
- Sponsor
- Leiden University Medical Center
- Start
- Sep 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1 trial of Shigella4V in shigellosis, sponsored by Leiden University Medical Center. Primary endpoint: Primary endpoint(s). Started Sep 2024; status: completed.
02
Drugs
Shigella4V
03
Conditions
shigellosis
Beyond the preview
Go deeper on NL-OMON58847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58847.